TipRanks
Bristol-Myers Squibb (CH:BMY)
:BMY
Switzerland Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

BMY Analyst Ratings

Moderate Buy
20Ratings
Moderate Buy
8 Buy
11 Hold
1 Sell
Based on 20 analysts giving stock ratings to
Bristol-Myers
Squibb
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BMY Stock 12 Month Forecast

Average Price Target

CHF55.68
▲(2.54% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is CHF55.68 with a high forecast of CHF67.92 and a low forecast of CHF33.13. The average price target represents a 2.54% change from the last price of CHF54.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"32":"CHF32","41":"CHF41","50":"CHF50","59":"CHF59","68":"CHF68"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":67.91857706,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF67.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55.67850829444445,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF55.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33.1310132,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF33.13</span>\n  </div></div>","useHTML":true}}],"tickPositions":[32,41,50,59,68],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.17,55.22758285076923,56.28516570153846,57.3427485523077,58.400331403076926,59.457914253846155,60.515497104615385,61.573079955384614,62.63066280615385,63.68824565692308,64.74582850769231,65.80341135846155,66.86099420923077,{"y":67.91857706,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.17,54.286039099572655,54.4020781991453,54.518117298717954,54.6341563982906,54.75019549786325,54.8662345974359,54.98227369700855,55.0983127965812,55.21435189615385,55.330390995726496,55.44643009529915,55.562469194871795,{"y":55.67850829444445,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.17,52.5516164,50.9332328,49.3148492,47.6964656,46.078082,44.4596984,42.8413148,41.2229312,39.604547600000004,37.986164,36.3677804,34.7493968,{"y":33.1310132,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.117,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.117,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.595,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.595,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.083,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.985,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.367,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.465,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.064,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.008,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.184,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.12,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.17,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF67.92Average Price TargetCHF55.68Lowest Price TargetCHF33.13
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:BMY
Terence Flynn
Morgan Stanley
Morgan Stanley
CHF33.13
Sell
-38.99%
Downside
Reiterated
09/25/26
Bristol-Myers Squibb: Pipeline Uncertainties and Limited IPF Upside Lead Flynn to Reiterate Sell Rating and Maintain $40 Price Target
RBC Capital Analyst forecast on CH:BMY
Trung Huynh
RBC Capital
RBC Capital
CHF53.01
Hold
-2.38%
Downside
Reiterated
09/21/26
RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)
Piper Sandler Analyst forecast on CH:BMY
David Amsellem
Piper Sandler
Piper Sandler
CHF62.12→CHF67.92
Buy
25.08%
Upside
Reiterated
09/16/26
Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler
HSBC Analyst forecast on CH:BMY
Rajesh Kumar
HSBC
HSBC
CHF49.7→CHF53.84
Hold
-0.85%
Downside
Reiterated
09/10/26
Bristol Myers price target raised to $65 from $60 at HSBCBristol Myers price target raised to $65 from $60 at HSBC
BMO Capital Analyst forecast on CH:BMY
Evan Seigerman
BMO Capital
BMO Capital
CHF49.7
Hold
-8.48%
Downside
Reiterated
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)
Scotiabank Analyst forecast on CH:BMY
Louise Chen
Scotiabank
Scotiabank
CHF49.7
Hold
-8.48%
Downside
Reiterated
09/09/26
Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)
Bernstein Analyst forecast on CH:BMY
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
08/20/26
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Revolution Medicines (NASDAQ: RVMD) and MDxHealth (NASDAQ: MDXH)
UBS Analyst forecast on CH:BMY
Michael Yee
UBS
UBS
CHF66.26
Buy
22.03%
Upside
Reiterated
08/20/26
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
Citi Analyst forecast on CH:BMY
Geoff Meacham
Citi
Citi
CHF57.98
Hold
6.78%
Upside
Reiterated
08/14/26
Citi Remains a Hold on Bristol-Myers Squibb (BMY)
William Blair Analyst forecast on CH:BMY
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/14/26
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
Barclays Analyst forecast on CH:BMY
Emily Field
Barclays
Barclays
CHF62.12
Buy
14.40%
Upside
Reiterated
08/11/26
Barclays Sticks to Its Buy Rating for Bristol-Myers Squibb (BMY)
J.P. Morgan Analyst forecast on CH:BMY
Chris Schott
J.P. Morgan
J.P. Morgan
CHF60.46
Buy
11.35%
Upside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Buy from J.P. Morgan
Argus Research Analyst forecast on CH:BMY
Jasper Hellweg
Argus Research
Argus Research
CHF62.12
Buy
14.40%
Upside
Upgraded
08/04/26
Bristol Myers upgraded to Buy from Hold at ArgusBristol Myers upgraded to Buy from Hold at Argus
Berenberg Bank Analyst forecast on CH:BMY
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
CHF49.7→CHF53.84
Hold
-0.85%
Downside
Reiterated
08/03/26
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
Bank of America Securities Analyst forecast on CH:BMY
Jason Gerberry
Bank of America Securities
Bank of America Securities
CHF58.81
Buy
8.30%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:BMY
Terence Flynn
Morgan Stanley
Morgan Stanley
CHF33.13
Sell
-38.99%
Downside
Reiterated
09/25/26
Bristol-Myers Squibb: Pipeline Uncertainties and Limited IPF Upside Lead Flynn to Reiterate Sell Rating and Maintain $40 Price Target
RBC Capital Analyst forecast on CH:BMY
Trung Huynh
RBC Capital
RBC Capital
CHF53.01
Hold
-2.38%
Downside
Reiterated
09/21/26
RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)
Piper Sandler Analyst forecast on CH:BMY
David Amsellem
Piper Sandler
Piper Sandler
CHF62.12→CHF67.92
Buy
25.08%
Upside
Reiterated
09/16/26
Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler
HSBC Analyst forecast on CH:BMY
Rajesh Kumar
HSBC
HSBC
CHF49.7→CHF53.84
Hold
-0.85%
Downside
Reiterated
09/10/26
Bristol Myers price target raised to $65 from $60 at HSBCBristol Myers price target raised to $65 from $60 at HSBC
BMO Capital Analyst forecast on CH:BMY
Evan Seigerman
BMO Capital
BMO Capital
CHF49.7
Hold
-8.48%
Downside
Reiterated
09/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)
Scotiabank Analyst forecast on CH:BMY
Louise Chen
Scotiabank
Scotiabank
CHF49.7
Hold
-8.48%
Downside
Reiterated
09/09/26
Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)
Bernstein Analyst forecast on CH:BMY
Courtney Breen
Bernstein
Bernstein
―
Hold
―
Reiterated
08/20/26
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Revolution Medicines (NASDAQ: RVMD) and MDxHealth (NASDAQ: MDXH)
UBS Analyst forecast on CH:BMY
Michael Yee
UBS
UBS
CHF66.26
Buy
22.03%
Upside
Reiterated
08/20/26
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
Citi Analyst forecast on CH:BMY
Geoff Meacham
Citi
Citi
CHF57.98
Hold
6.78%
Upside
Reiterated
08/14/26
Citi Remains a Hold on Bristol-Myers Squibb (BMY)
William Blair Analyst forecast on CH:BMY
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/14/26
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
Barclays Analyst forecast on CH:BMY
Emily Field
Barclays
Barclays
CHF62.12
Buy
14.40%
Upside
Reiterated
08/11/26
Barclays Sticks to Its Buy Rating for Bristol-Myers Squibb (BMY)
J.P. Morgan Analyst forecast on CH:BMY
Chris Schott
J.P. Morgan
J.P. Morgan
CHF60.46
Buy
11.35%
Upside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Buy from J.P. Morgan
Argus Research Analyst forecast on CH:BMY
Jasper Hellweg
Argus Research
Argus Research
CHF62.12
Buy
14.40%
Upside
Upgraded
08/04/26
Bristol Myers upgraded to Buy from Hold at ArgusBristol Myers upgraded to Buy from Hold at Argus
Berenberg Bank Analyst forecast on CH:BMY
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
CHF49.7→CHF53.84
Hold
-0.85%
Downside
Reiterated
08/03/26
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
Bank of America Securities Analyst forecast on CH:BMY
Jason Gerberry
Bank of America Securities
Bank of America Securities
CHF58.81
Buy
8.30%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
CELCCelcuity
ONCBeOne Medicines
GHGuardant Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bristol-Myers Squibb

3 Months
Srikripa DevarakondaTruist Financial
Success Rate
12/16 ratings generated profit
75%
Average Return
+9.46%
Copying Srikripa Devarakonda's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +9.46% per trade.
1 Year
David RisingerLeerink Partners
Success Rate
16/19 ratings generated profit
84%
Average Return
+15.03%
Copying David Risinger's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +15.03% per trade.
2 Years
David RisingerLeerink Partners
Success Rate
18/19 ratings generated profit
95%
Average Return
+18.24%
Copying David Risinger's trades and holding each position for 2 Years would result in 94.74% of your transactions generating a profit, with an average return of +18.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BMY Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
14
19
22
21
16
Hold
30
27
30
28
31
Sell
1
1
2
2
3
Strong Sell
0
0
0
0
0
total
45
47
54
51
50
In the current month, BMY has received 16 Buy Ratings, 31 Hold Ratings, and 3 Sell Ratings. BMY average Analyst price target in the past 3 months is 55.68.
Each month's total comprises the sum of three months' worth of ratings.

BMY Financial Forecast

BMY Earnings Forecast

Next quarter’s earnings estimate for BMY is CHF1.43 with a range of CHF1.32 to CHF1.59. The previous quarter’s EPS was CHF1.69. BMY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BMY has Performed in-line its overall industry.
Next quarter’s earnings estimate for BMY is CHF1.43 with a range of CHF1.32 to CHF1.59. The previous quarter’s EPS was CHF1.69. BMY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BMY has Performed in-line its overall industry.

BMY Sales Forecast

Next quarter’s sales forecast for BMY is CHF10.45B with a range of CHF9.89B to CHF10.82B. The previous quarter’s sales results were CHF10.75B. BMY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BMY has Performed in-line its overall industry.
Next quarter’s sales forecast for BMY is CHF10.45B with a range of CHF9.89B to CHF10.82B. The previous quarter’s sales results were CHF10.75B. BMY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BMY has Performed in-line its overall industry.

BMY Stock Forecast FAQ

What is CH:BMY’s average 12-month price target, according to analysts?
Based on analyst ratings, Bristol-Myers Squibb’s 12-month average price target is 55.68.
    What is CH:BMY’s upside potential, based on the analysts’ average price target?
    Bristol-Myers Squibb has 2.54% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Bristol-Myers Squibb a Buy, Sell or Hold?
          Bristol-Myers Squibb has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 11 hold ratings and 1 sell ratings.
            What is Bristol-Myers Squibb’s share price target?
            The average share price target for Bristol-Myers Squibb is 55.68. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF67.92 ,and the lowest forecast is CHF33.13. The average share price target represents 2.54% Increase from the current price of CHF54.3.
              What do analysts say about Bristol-Myers Squibb?
              Bristol-Myers Squibb’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of Bristol-Myers Squibb?
                To buy shares of CH:BMY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.